These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24029686)

  • 1. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection.
    Cárdenas AM; Baughan E; Hodinka RL
    J Clin Virol; 2013 Dec; 58 Suppl 1():e97-e103. PubMed ID: 24113294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance of the Multispot HIV-1/HIV-2 rapid test to correctly differentiate HIV-2 from HIV-1 infection in screening algorithms using third and fourth generation assays and to identify cross reactivity with the HIV-1 Western Blot.
    Ramos EM; Harb S; Dragavon J; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e104-7. PubMed ID: 24342468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Multispot rapid HIV-1/HIV-2 differentiation assay is comparable with the Western blot and an immunofluorescence assay at confirming HIV infection in a prospective study in three regions of the United States.
    Pandori MW; Westheimer E; Gay C; Moss N; Fu J; Hightow-Weidman LB; Craw J; Hall L; Giancotti FR; Mak ML; Madayag C; Tsoi B; Louie B; Patel P; Owen SM; Peters PJ
    J Clin Virol; 2013 Dec; 58 Suppl 1():e92-6. PubMed ID: 24342485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
    Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
    J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.
    Wesolowski LG; Delaney KP; Hart C; Dawson C; Owen SM; Candal D; Meyer WA; Ethridge SF; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S45-9. PubMed ID: 21995934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm.
    Nasrullah M; Wesolowski LG; Meyer WA; Owen SM; Masciotra S; Vorwald C; Becker WJ; Branson BM
    AIDS; 2013 Mar; 27(5):731-7. PubMed ID: 23135170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011.
    Masciotra S; Smith AJ; Youngpairoj AS; Sprinkle P; Miles I; Sionean C; Paz-Bailey G; Johnson JA; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e8-e12. PubMed ID: 24342483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection.
    Curtis KA; Rudolph DL; Pan Y; Delaney K; Anastos K; DeHovitz J; Kassaye SG; Hanson CV; French AL; Golub E; Adimora AA; Ofotokun I; Bolivar H; Kempf MC; Peters PJ; Switzer WM
    PLoS One; 2021; 16(7):e0242641. PubMed ID: 34197451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots.
    Linley L; Ethridge SF; Oraka E; Owen SM; Wesolowski LG; Wroblewski K; Landgraf KM; Parker MM; Brinson M; Branson BM
    J Clin Virol; 2013 Dec; 58 Suppl 1():e108-12. PubMed ID: 24342469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fourth generation Alere
    Livant E; Heaps A; Kelly C; Maharaj R; Samsunder N; Nhlangulela L; Karugaba P; Panchia R; Marrazzo J; Chirenje ZM; Parikh UM;
    J Clin Virol; 2017 Sep; 94():15-21. PubMed ID: 28710996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
    Fordan S; Bennett B; Lee M; Crowe S
    J Clin Virol; 2017 Jun; 91():79-83. PubMed ID: 28434810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.